Parmar Kush's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Aug 10, 2026
- Accession no.
- 0001664281-26-000004
- Filed
- Aug 10, 2026, 7:54 PM ET
- Trade date
- Aug 6-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.08M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | SSaleDisposed | −10,494 | $7.00 | −$73,458 | 2,836,098 | Indirect | |
| Aug 7, 2026 | Common Stock | SSaleDisposed | −52,317 | $6.85 | −$358,371.45 | 2,783,781 | Indirect | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −92,444 | $7.00 | −$647,108 | 2,691,337 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.